The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Cancer Risk and Low-Penetrance Susceptibility Genes in Gene-Environment Interactions
Abstract
PURPOSE: To provide a concise review for human cancer risk related to low-penetrance genes and their effects on environmental carcinogen exposure. METHODS: Citation of relevant and recent references for molecular epidemiology, focusing on lung cancer, ethical issues, and some clinical implications of recent molecular epidemiology studies. RESULTS: Low-penetrance genes contribute to cancer risk by augmenting the effects of carcinogen exposures. These exposures can be measured in the body through molecular dosimetry (ie, the amount of DNA damage), which reflects a biologically effective dose. The examination of tumors and the mutations within tumor suppressor genes, such as p53, can provide etiologic clues for both exposure and susceptibility. Although many studies have focused on carcinogen metabolism and cancer risk, more recent studies are considering DNA repair. Also, we are learning that behavior, such as tobacco addiction, also may be genetically controlled. CONCLUSION: Sporadic cancers are caused by gene n-environment n interactions rather than a dominant effect by a specific gene, environmental exposure, or gene-environment interaction. New paradigms, where we categorize genes as caretaker or gatekeeper genes, will allow for new hypotheses to be tested and will require advanced methods of analysis. The goal of molecular epidemiology is to develop risk assessment models for individuals, but currently the most achievable goal will be population risk assessment and a better understanding of carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · The Use of Human Cells for the Evaluation of Risk from Physical and Chemical Agents · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,501
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Self-citationKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
A role for sunlight in skin-cancer – UV-induced p53 mutations in squamous-cell carcinoma
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., & Pontén, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10124 · Cited by 1,959
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Self-citationSunburn and p53 in the onset of skin cancer
Ziegler, A., Jonason, A. S., Leffellt, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., & Brash, D. E. (1994) · Nature · doi:10.1038/372773a0 · Cited by 1,497
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
Self-citationA Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,261
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Recent Advances in Chemoprevention of Cancer
Hong, W. K., & Sporn, M. B. (1997) · Science · doi:10.1126/science.278.5340.1073 · Cited by 827
Rebbeck, T. R. (1997) · PubMed · Cited by 729
Harris, C. C. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1442 · Cited by 680
Self-citationBrennan, J. A., Boyle, J. O., Koch, W. M., Goodman, S. N., Hruban, R. H., Eby, Y. J., Couch, M. J., Forastiere, A. A., & Sidransky, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321104 · Cited by 658
Environment and Cancer: Who Are Susceptible?
Perera, F. P. (1997) · Science · doi:10.1126/science.278.5340.1068 · Cited by 638
Human Cancer Syndromes: Clues to the Origin and Nature of Cancer
Fearon, E. R. (1997) · Science · doi:10.1126/science.278.5340.1043 · Cited by 605
The Use and Interpretation of Commercial APC Gene Testing for Familial Adenomatous Polyposis
Giardiello, F. M., Brensinger, J. D., Petersen, G. M., Luce, M. C., Hylind, L. M., Bacon, J. A., Booker, S. V., Parker, R. D., & Hamilton, S. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703203361202 · Cited by 498
Ryberg, D. (1997) · Carcinogenesis · doi:10.1093/carcin/18.7.1285 · Cited by 417
DNA repair and aging in basal cell carcinoma: a molecular epidemiology study.
Wei, Q., Matanoski, G. M., Farmer, E. R., Hedayati, M. A., & Grossman, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1614 · Cited by 414
Metabolic oxidation phenotypes as markers for susceptibility to lung cancer
Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J., & Hetzel, M. R. (1984) · Nature · doi:10.1038/312169a0 · Cited by 383
BCL2 translocation frequency rises with age in humans
Liu, Y., Hernandez, A. M., Shibata, D., & Cortopassi, G. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8910 · Cited by 358
Nakazawa, H., English, D., Randell, P. L., Nakazawa, K., Martel, N., Armstrong, B. K., & Yamasaki, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.360 · Cited by 330
Marchand, L. L., Sivaraman, L., Pierce, L. J., Seifried, A., Lum, A., Wilkens, L. R., & Lau, A. F. (1998) · PubMed · Cited by 290
Evidence suggesting the role of specific genetic factors in cigarette smoking.
Lerman, C., Caporaso, N. E., Audrain, J., Main, D., Bowman, E. D., Lockshin, B., Boyd, N. R., & Shields, P. G. (1999) · Health Psychology · doi:10.1037//0278-6133.18.1.14 · Cited by 279
Self-citationGenetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90132-4 · Cited by 274
The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking
Comings, D. E., Ferry, L., Bradshaw-Robinson, S., Burchette, R., Chiu, C., & Muhleman, D. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00006 · Cited by 263
Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk.
McWilliams, J. E., Sanderson, B. J. S., Harris, E. L., Richert-Boe, K. E., & Henner, W. D. (1995) · PubMed · Cited by 240
Uematsu, F., Kikuchi, H., Motomiya, M., Abe, T., Sagami, I., Ohmachi, T., Wakui, A., Kanamaru, R., & Watanabe, M. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01838.x · Cited by 218
D2 dopamine receptor gene and cigarette smoking: A reward gene?
Noble, E. P., Jeor, S. T. S., Ritchie, T., Syndulko, K., Jeor, S. C. S., Fitch, R. J., Brunner, R. L., & Sparkes, R. S. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90127-9 · Cited by 209
Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N. R., Bowman, E. D., & Shields, P. G. (1998) · Health Psychology · doi:10.1037//0278-6133.17.1.56 · Cited by 198
Self-citationHuman Lung Carcinogen--DNA Adduct Levels Mediated by Genetic Polymorphisms In Vivo
Kato, S., Bowman, E. D., Harrington, A. M., Blomeke, B., & Shields, P. G. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.902 · Cited by 197
Self-citationEnvironmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women
Bennett, W. P., Alavanja, M. C. R., Blomeke, B., Vahakangas, K. H., Castren, K., Welsh, J. A., Bowman, E. D., Khan, M. A., Flieder, D. B., & Harris, C. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2009 · Cited by 192
Self-citationDopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians.
Shields, P. G., Lerman, C., Audrain, J. E., Bowman, E. D., Main, D., Boyd, N. R., & Caporaso, N. E. (1998) · PubMed · Cited by 155
Self-citationCOMMENTARY: Nature and nurture: possibilities for cancer control
Doll, R. (1996) · Carcinogenesis · doi:10.1093/carcin/17.2.177 · Cited by 117
Genetic Testing for Cancer Risk
Ponder, B. A. J. (1997) · Science · doi:10.1126/science.278.5340.1050 · Cited by 114
The Natural Somatic Mutation Frequency and Human Carcinogenesis
Simpson, A. G. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60100-1 · Cited by 112
Uematsu, F., Ikawa, S., Kikuchi, H., Sagami, I., Kanamaru, R., Abé, T., Satoh, K., Motomiya, M., & Watanabe, M. (1994) · Pharmacogenetics · doi:10.1097/00008571-199404000-00002 · Cited by 104
Predictive Genetic Testing: From Basic Research to Clinical Practice
Holtzman, N. A., Murphy, P. D., Watson, M. S., & Barr, P. A. (1997) · Science · doi:10.1126/science.278.5338.602 · Cited by 75
Genetic Epidemiology and the Future of Disease Prevention and Public Health
Khoury, M. J. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017940 · Cited by 71
Holtzman, N. A., Murphy, P. D., Watson, M. S., & Barr, P. A. (1997) · PubMed · Cited by 69
Sex Steroid Hormones and Genetic Susceptibility to Breast and Prostate Cancer
Feigelson, H. S., Ross, R. K., Yu, M. C., Coetzee, G. A., Reichardt, J. K. V., & Henderson, B. E. (1998) · Drug Metabolism Reviews · doi:10.3109/03602539808996320 · Cited by 15
Cited by
(EFSA), E. F. S. A. (2005) · EFSA Journal · doi:10.2903/j.efsa.2005.282 · Cited by 582
Modifier genes in mice and humans
Nadeau, J. H. (2001) · Nature Reviews Genetics · doi:10.1038/35056009 · Cited by 569
Genetic research and health disparities.
Sankar, P. (2004) · JAMA · doi:10.1001/jama.291.24.2985 · Cited by 319
Gilliland, F. D., Li, Y.-F., Dubeau, L., Berhane, K., Avol, E., McConnell, R., Gauderman, W. J., & Peters, J. M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112064 · Cited by 289
Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle–Control Genes
Wu, X., Gu, J., Grossman, H. B., Amos, C. I., Etzel, C., Huang, M., Zhang, Q., Millikan, R. E., Lerner, S., Dinney, C. P., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/500848 · Cited by 273
Metadata
- Authors
- Shields, P. G., & Harris, C. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-06-11
- Volume
- 18
- Issue
- 11
- Pages
- 2309-2315
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1821184592
- Cited by
- 275
- References
- 47
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.